Internal Medicine, Nephrology · Garden Grove, CA
NPI
1396727764
Since 2005
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
3
Medicare group memberships
Hospitals
0
Hospital affiliations
12665 Garden Grove Blvd, Suite 503
Garden Grove, CA, 92843
Phone (714) 530-3740
Groups this clinician bills Medicare through
Medicare paid, 2024
$321K
5,209 services
Medicare patients, 2024
529
Average age 79
Drug cost, 2024
$4.9M
35,873 prescriptions
Company payments, 2025
$2,152
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Hong S Kim was code 99213 (office e&m - established), 1,549 times for 435 patients. In total Hong S Kim billed 5,209 services in 50 codes, and Medicare paid $321K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-11-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 1,549 | 435 | $65.68 | $102K |
| 36415 Venipuncture Blood Collection | Office | 925 | 392 | $8.65 | $8,001 |
| 96372 Injection Administration | Office | 466 | 160 | $11.09 | $5,169 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 375 | 375 | $138.06 | $52K |
| 99497 Care Management/Coordination | Office | 372 | 371 | $57.93 | $22K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 202 | 31 | $0.09 | $17.34 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 195 | 94 | $0.83 | $163 |
| 90961 ESRD Related Services (not dialysis) | Office | 157 | 32 | $240.60 | $38K |
| 90960 ESRD Related Services (not dialysis) | Office | 148 | 20 | $289.33 | $43K |
| 99232 Hospital E&M - Subsequent | Facility | 101 | 28 | $61.50 | $6,211 |
| 99233 Hospital E&M - Subsequent | Facility | 77 | 25 | $93.32 | $7,185 |
| 81002 Clinical Chemistry | Office | 56 | 43 | $3.41 | $191 |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 52 | 12 | $0.34 | $17.59 |
| 93000 Electrocardiogram | Office | 51 | 50 | $11.25 | $574 |
| 99223 Hospital E&M - Initial | Facility | 42 | 32 | $136.44 | $5,730 |
By year: 2022 $865K for 14,311 services; 2023 $480K for 7,619 services; 2024 $321K for 5,209 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 925 | 392 | $8.65 | $8,001 |
| 81002 Clinical Chemistry | 56 | 43 | $3.41 | $191 |
Medicare prescription drug claims, 2024
In 2024, the drug Hong S Kim prescribed most often to Medicare patients was Amlodipine Besylate, with 2,565 prescriptions and refills. In total Hong S Kim wrote 35,873 Medicare prescriptions that cost $4.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 2,565 | 5,196 | 528 | $7,771 |
| Rosuvastatin Calcium Generic | 2,266 | 5,097 | 536 | $23K |
| Losartan Potassium Generic | 1,820 | 3,769 | 369 | $11K |
| Atorvastatin Calcium Generic | 1,494 | 3,076 | 306 | $9,081 |
| Vascepa Icosapent Ethyl | 1,004 | 1,169 | 137 | $324K |
| Tamsulosin Hcl Generic | 835 | 1,792 | 191 | $8,139 |
| Creon Lipase/Protease/Amylase | 746 | 901 | 171 | $897K |
| Metformin Hcl Generic | 690 | 1,569 | 153 | $3,821 |
| Labetalol Hcl Generic | 606 | 1,147 | 119 | $13K |
| Levothyroxine Sodium Generic | 603 | 1,364 | 135 | $5,226 |
| Alendronate Sodium Generic | 596 | 1,189 | 138 | $3,246 |
| Pantoprazole Sodium Generic | 589 | 1,036 | 139 | $4,186 |
| Metoprolol Succinate Generic | 583 | 1,080 | 117 | $4,912 |
| Furosemide Generic | 552 | 928 | 113 | $1,610 |
| Gabapentin Generic | 511 | 710 | 107 | $2,656 |
Brand drugs: 6,605 claims; generic drugs: 28,720 claims; opioid claims: 34.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Hong S Kim $2,152 ($2,152 in general payments such as food, travel and fees) from 21 companies. The largest payer was Abbvie Inc. with $528.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 37 | $528 |
| Aimmune Therapeutics, Inc. | 20 | $519 |
| Fresenius USA Marketing, Inc. | 7 | $171 |
| Lilly USA, LLC LLY | 2 | $151 |
| Amgen Inc. AMGN | 6 | $139 |
| Lundbeck LLC | 5 | $118 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 4 | $58.57 |
| Dexcom, Inc. DXCM | 2 | $53.97 |
| Travere Therapeutics, Inc. TVTX | 2 | $50.44 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $48.36 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.